Lexicon Pharmaceuticals
LXRX
#6234
Rank
A$1.43 B
Marketcap
A$3.24
Share price
-1.74%
Change (1 day)
76.46%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$94.46 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are A$94.46 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.11 B-52.83%
2024-12-31A$0.24 B22.51%
2023-12-31A$0.20 B76.43%
2022-12-31A$0.11 B252.66%
2021-12-31A$32.15 M-47.85%
2020-12-31A$61.66 M-85.64%
2019-12-31A$0.42 B-2.6%
2018-12-31A$0.44 B-6.55%
2017-12-31A$0.47 B6.85%
2016-12-31A$0.44 B-12.16%
2015-12-31A$0.50 B119.52%
2014-12-31A$0.22 B96.36%
2013-12-31A$0.11 B15.28%
2012-12-31A$0.10 B-22%
2011-12-31A$0.12 B9.88%
2010-12-31A$0.11 B12.45%
2009-12-31A$0.10 B12.72%
2008-12-31A$93.09 M-1.61%
2007-12-31A$94.62 M-28.8%
2006-12-31A$0.13 B-26.84%
2005-12-31A$0.18 B55.52%
2004-12-31A$0.11 B-26.42%
2003-12-31A$0.15 B180.6%
2002-12-31A$56.56 M33.54%
2001-12-31A$42.35 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Thermo Fisher Scientific
TMO
A$87.67 B 92,709.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$5.56 B 5,786.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$13.52 B 14,218.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$2.18 B 2,211.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.76 B 710.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.10 B 1,068.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$0.77 B 717.99%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.40 B 3,506.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$5.27 M-94.42%๐Ÿ‡บ๐Ÿ‡ธ USA